Oliveira Alexandra M L, Machado Mónica, Silva Gabriela A, Bitoque Diogo B, Tavares Ferreira Joana, Pinto Luís Abegão, Ferreira Quirina
Instituto de Telecomunicações, Avenida Rovisco Pais, 1049-001 Lisbon, Portugal.
iNOVA4Health, CEDOC Chronic Diseases Research Centre, NOVA Medical School, Universidade Nova de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, Portugal.
Nanomaterials (Basel). 2022 Mar 30;12(7):1149. doi: 10.3390/nano12071149.
Graphene oxide has been used in different fields of nanomedicine as a manager of drug delivery due to its inherent physical and chemical properties that allow its use in thin films with biomedical applications. Several studies demonstrated its efficacy in the control of the amount and the timely delivery of drugs when it is incorporated in multilayer films. It has been demonstrated that oxide graphene layers are able to work as drug delivery or just to delay consecutive drug dosage, allowing the operation of time-controlled systems. This review presents the latest research developments of biomedical applications using graphene oxide as the main component of a drug delivery system, with focus on the production and characterization of films, in vitro and in vivo assays, main applications of graphene oxide biomedical devices, and its biocompatibility properties.
由于氧化石墨烯具有固有的物理和化学性质,使其可用于生物医学应用的薄膜中,因此它已在纳米医学的不同领域用作药物递送载体。多项研究表明,当将其掺入多层膜中时,它在控制药物的量和适时递送方面具有功效。已经证明,氧化石墨烯层能够作为药物递送载体起作用,或者只是延迟连续给药剂量,从而实现时间控制系统的运作。本综述介绍了以氧化石墨烯作为药物递送系统主要成分的生物医学应用的最新研究进展,重点关注薄膜的制备和表征、体外和体内试验、氧化石墨烯生物医学器件的主要应用及其生物相容性。